Chemistry: molecular biology and microbiology – Process of mutation – cell fusion – or genetic modification – Fusion of cells
Reexamination Certificate
1995-04-26
2004-08-31
Caputa, Anthony C. (Department: 1642)
Chemistry: molecular biology and microbiology
Process of mutation, cell fusion, or genetic modification
Fusion of cells
C435S341000, C530S388100, C530S388260, C530S388500
Reexamination Certificate
active
06783986
ABSTRACT:
Sucrose phosphate synthetase (SPS), its preparation process, its complementary DNA and the use of the complementary DNA to modify the expression of the SPS in vegetable cells.
The present invention relates to saccharose phosphate synthetase (SPS), its preparation process, its complementary DNA and the use of the latter to modify the rate of expression of SPS in vegetable cells.
A subject of the invention is proteins having the activity of saccharose phosphate synthetase (SPS).
By vegetable cell is meant all plant cells being able to form undifferentiated tissue such as calluses or differentiated tissues such as embryos, certain parts of plants, whole plants or also seeds.
By plant is meant notably plants producing seeds, for example the grasses such as straw cereals such as wheat, barley, maize or oats, the legumes such as soya, oleaginous plants such as sunflowers, plants with tubers such as potatoes, plants with roots such as beetroots or fruits such as tomatoes.
More particularly a subject of the invention is saccharose phosphate synthetase and notably the saccharose phosphate synthetase of plants.
By plants is meant for example the grasses such as for example wheat, barley, maize, sugar cane, vegetables such as tomatoes and soya, fruits, such as apples and bananas.
Saccharose phosphate synthetase is a key enzyme in the regulation mechanisms of saccharose, but also in the regulation mechanisms of the distribution of carbon between starch and saccharose in photosynthesis (see on this subject the article by Jack PREISS in TIBS January 1984, pages 24 and following, or also the article by Mark STITT and Coll. in Biochemistry of Plants vol. 10, 1987 pages 327 and following).
The SPS appears to be specific to the species concerned; Joan L-Walker and Steven C. Huber who have purified and carried out a preliminary characterization of the saccharose phosphate of spinach indicate clearly that the antibodies obtained recognize exclusively the SPS of spinach (cf PLANT PHYSIOL (1989) 89, 518-524).
More precisely a subject of the invention is the SPS of maize.
The SPS of maize can exist in a pure or practically pure form.
More precisely a subject of the invention is the proteins defined previously of molecular weight of the order of 110 to 130 kD appearing in the monomer, dimer or tetramer form and their derivatives having at least one peptide whose amino acid sequence is the following:
ThrTrpIleLys (SEQ ID NO: 1)
TyrValValGluLeuAlaArg (SEQ ID NO: 2)
SerMetProProIleTrpAlaGluValMetArg (SEQ ID NO: 3)
LeuArgProAspGlnAspTyrLeuMetHisIleSerHisArg (SEQ ID NO: 4)
TrpSerHisAspGlyAlaArg (SEQ ID NO: 5)
Notably a subject of the invention is the proteins defined previously having the amino acid sequence described in FIG.
7
. (SEQ ID NO: 11)
Also a subject of the invention is the derivatives of the proteins defined previously modified by genetic engineering techniques and presenting the activity of the SPS.
Also a subject of the invention is a preparation process characterized in that:
a) an extract is made from parts of the plants preserved at low temperature by grinding, centrifugation and filtration,
b) the extract obtained is enriched in SPS protein by precipitation in an appropriate solvent, centrifugation and solubilisation of the precipitate obtained in a buffer solution,
c) the active protein thus obtained is purified by chromatography and if desired,
d) the hybridomas and monoclonal antibodies are prepared from an antigen solution obtained from one of the preparations obtained in paragraphs a), b), and c) above,
e) the hybridomas are screened and the monoclonal antibody or antibodies directed specifically against the SPS are selected,
f) the SPS obtained is purified by means of the antibodies prepared in this way.
More precisely a subject of the invention is a process characterized in that:
a) an extract is made from parts of maize plants preserved at low temperature by grinding, centrifugation and filtration,
b) the extract obtained is enriched in proteins by precipitation in polyethyleneglycol, centrifugation and solubilisation of the precipitate obtained in a buffer solution,
c) the SPS protein thus obtained is purified by low pressure anion exchange chromatography, then by chromatography on heparin Sepharose, then by high pressure anion exchange chromatography,
d) the active fractions are purified by passage through 2 high pressure chromatography columns, and, if desired,
e) the hybridomas and monoclonal antibodies are prepared from an antigen solution obtained from a preparation a), b), c),
f) the hybridomas are screened and the antibodies directed specifically against the SPS are selected,
g) the SPS obtained previously is purified by means of antibodies thus prepared.
In a preferred embodiment:
the maize used is a maize of PIONEER 3184 strain,
the parts of maize plants used are leaves preserved at low temperature for example between −50° C. and −90° C.,
the purification in polyethyleneglycol (PEG) takes place in two stages:
a first precipitation where the final concentration of PEG is close to 6%,
a second precipitation where the final concentration of PEG is close to 12%.
the various chromatographies are carried out as follows:
1st chromatography: DEAE Sepharose,
2nd chromatography: heparin Sepharose: it should be noted that the preparation thus obtained can be preserved for several days without a major loss of activity,
3rd HPLC chromatography: Mono Q chromatography,
4th HPLC chromatography: hydroxylapatite,
5th HPLC chromatography: DEAE.
in the course of these various purification stages and the following, the measurement of the SPS activity is preferably carried out using two different methods:
a) a method based on a colorimetric test or a resorcinal test,
b) a method based on the determination of one of the products formed during the transformation reactions involving the SPS. These two methods are detailed in the experimental part set out hereafter.
mice are immunized with several injections of the purified enzymatic preparation.
Different mouse types can be used, for example BALB/C mice.
The antigen is used in the complete Freund adjuvant then in the incomplete Freund adjuvant.
Several injections of the antigen are administered to the mice: good results were obtained with three injections of mono Q fractions followed by three injections of final fractions (on days 0, 14, 27, 60, 90 and 105 for example).
The first injections are carried out by subcutaneous route, for example in the foot pads, the last injection is carried out by intravenous route in the tail for example.
the preparation of cellular suspensions of spleen thus immunized is treated in a clonic fashion.
The stages of fusion with myeloma cells, preservation of the hybridomas, cloning and production of the antibodies are achieved according to known methods.
To detect the hybridomas secreting the antibodies directed against the antigen, two methods are used to select the detection antibodies of the secreting hybridomas directed against the immunization antigen:
a method of detection of antibody inhibitors of SPS activity,
a method of antibody activity directed against SPS activity.
These methods are preferably those described in the experimental part.
Also a subject of the invention is the cell lines of the hybridomas obtained and notably the cell lines of the following hybridomas:
SPA 2-2-3: I-971
SPA 2-2-22: I-970
SPA 2-2-25: I-972
SPB 3-2-19: I-973
SPB 5-2-10: I-974
SPB 5-4-2: I-975
SPB 13-1-7: 1-976
SPB 13-2-2: I-977
which were deposited on Jun. 11, 1990 with the Collection Nationale de Culture de Microorganismes (CNCM—Institute Pasteur) under the numbers mentioned located at 28, rue de Docteur Roux, 75724 Paris Cedex 15, France.
Also a subject of the invention is monoclonal antibodies directed specifically against the SPS.
Also a subject of the invention is a preparation process for proteins characterized in that a preparation containing said proteins is passed through a chromatography column containing the monoclonal antibodies directed specifically against said proteins and in this way the desired p
Bruneau Jean Michel
Gervais Monica
Lando Danielle
Van Assche Charles
Voelker Toni Alois
Aventis Crop Sciences GmbH
Bierman, Muserlian and Lucas
Canella Karen A.
Caputa Anthony C.
LandOfFree
Sucrose phosphate synthetase (SPS), a preparation method and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sucrose phosphate synthetase (SPS), a preparation method and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sucrose phosphate synthetase (SPS), a preparation method and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3288939